A schematic diagram of cancer cell specific anti-cancer drug precursor nanopharmaceutical technology (IMAGE)

National Research Council of Science & Technology

A schematic diagram of cancer cell specific anti-cancer drug precursor nanopharmaceutical technology

Caption

This cancer cell specific anti-cancer drug precursor (SMAC-FRG-DOX) formed itself by hydrophobic interaction within the molecule without the use of additional polymers and drug carriers, and is optionally activated by cathesin B, an overexpressed enzyme within the cancer cell, releasing SMAC and Doxorubicin simultaneously.

Credit

Korea Institue of Science and Technology(KIST)

Usage Restrictions

The sources of photos and research results from KIST must be specified.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.